BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15133815)

  • 61. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 128-channel somatosensory evoked potentials in the differential diagnosis of parkinsonian disorders.
    van de Wassenberg WJ; van der Hoeven JH; Leenders KL; Maurits NM
    Parkinsonism Relat Disord; 2009 Sep; 15(8):564-71. PubMed ID: 19303347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Applause sign in Parkinsonian disorders and Huntington's disease.
    Wu LJ; Sitburana O; Davidson A; Jankovic J
    Mov Disord; 2008 Dec; 23(16):2307-11. PubMed ID: 18972544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.
    Blain CR; Barker GJ; Jarosz JM; Coyle NA; Landau S; Brown RG; Chaudhuri KR; Simmons A; Jones DK; Williams SC; Leigh PN
    Neurology; 2006 Dec; 67(12):2199-205. PubMed ID: 17190944
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Atypical Parkinson syndromes--recent advances in diagnosis and therapy].
    Duerr S; Wenning GK; Seppi K; Poewe W
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):492-500. PubMed ID: 22457226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS
    Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impairment of transcallosal inhibition in patients with corticobasal degeneration.
    Trompetto C; Buccolieri A; Marchese R; Marinelli L; Michelozzi G; Abbruzzese G
    Clin Neurophysiol; 2003 Nov; 114(11):2181-7. PubMed ID: 14580617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.
    Seppi K; Poewe W
    Neuroimaging Clin N Am; 2010 Feb; 20(1):29-55. PubMed ID: 19959017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Neuroimaging features in progressive supranuclear palsy and corticobasal degeneration].
    Mori E
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1158-61. PubMed ID: 12784693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Olfactory function in atypical parkinsonian syndromes.
    Wenning GK; Shephard B; Hawkes C; Petruckevitch A; Lees A; Quinn N
    Acta Neurol Scand; 1995 Apr; 91(4):247-50. PubMed ID: 7625148
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mixing pro- and antisaccades in patients with parkinsonian syndromes.
    Rivaud-Péchoux S; Vidailhet M; Brandel JP; Gaymard B
    Brain; 2007 Jan; 130(Pt 1):256-64. PubMed ID: 17124191
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging.
    da Rocha AJ; Maia AC; da Silva CJ; Braga FT; Ferreira NP; Barsottini OG; Ferraz HB
    Mov Disord; 2007 Jan; 22(2):238-44. PubMed ID: 17133514
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Atypical Parkinson syndromes].
    Strzelczyk A; Möller JC; Stamelou M; Matusch A; Oertel WH
    Nervenarzt; 2008 Oct; 79(10):1203-20; quiz 1221-2. PubMed ID: 18751965
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy.
    Soliveri P; Piacentini S; Paridi D; Testa D; Carella F; Girotti F
    Neurol Sci; 2003 Oct; 24(3):213-4. PubMed ID: 14598093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transcallosal inhibition in patients with callosal infarction.
    Li JY; Lai PH; Chen R
    J Neurophysiol; 2013 Feb; 109(3):659-65. PubMed ID: 23136342
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk].
    Nakanishi I; Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2003 Jul; 55(7):605-8. PubMed ID: 12910995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.